➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Medtronic
AstraZeneca
Merck
McKesson

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC (D. Del. 2010)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC (D. Del. 2010)

Docket   Start Trial Date Filed 2010-12-15
Court District Court, D. Delaware Date Terminated 2013-02-08
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Defendant Referred To Mary Pat Thynge
Parties ACTAVIS ELIZABETH LLC; ACTAVIS INC.; CADILA HEALTHCARE LIMITED; J. RETTENMAIER & SOHNE GMBH + CO. KG; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; PAR PHARMACEUTICAL COMPANIES INC.; PAR PHARMACEUTICAL INC.; PROCOM ONE INC.; SOMAXON PHARMACEUTICALS INC.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 6,103,219; 6,211,229; 6,217,909; 7,915,307
Attorneys Anne Shea Gaza; Aziz Burgy; Brian P. Murray; Christine Duh; Daniel G. Brown; David B. Abramowitz; David Ellis Moore; Dominick T. Gattuso; Emily R. Whelan; Francis J. Murphy , Jr.; Frederick L. Cottrell , III; Jack B. Blumenfeld; Janine A. Carlan; Jason James Rawnsley; Jeffrey A Marx; Jeremy A. Tigan; John C. Phillips , Jr.; John D. Polivick; Joseph T. Jaros; Lisa J. Pirozzolo; Maryellen Noreika; Megan C. Haney; Michael J. Gaertner; Mitchell Epner; Nathan R. Speed; Paul J. Molino; Richard L. Horwitz; Scott B. Feder; Thomas R. Burns; Wendy L. Devine; William A. Rakoczy
Firms Murphy, Spadaro & Landon
Link to Docket External link to docket
Small Molecule Drugs cited in Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC (D. Del. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-12-15 1 Complaint for patent infringement of U.S. Patent No. 6,211,229 (“the ’229 patent”), arising under the patent laws…the ’229 patent, entitled “Treatment of Transient and Short Term lnsomnia,” Which the U.S. Patent and Trademark…copy of the ’229 patent is attached hereto as Exhibit A. The claims of the ’229 patent are valid and enforceable…covered by one or more claims of the ’229 patent. The ’229 patent has been listed in connection with SILENOR…of the ’229 patent constitutes infringement of one or more of the claims of the ’229 patent under 35 U. External link to document
2011-02-07 21 Patent/Trademark Report to Commissioner ,725,884; 5,866,166; 5,948,438; 6,103,219; 6,217,909;. (Phillips, John) (Entered: 02/07/2011) 7 February… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,585,115; 5,725,884…2010 8 February 2013 1:10-cv-01100 830 Patent Defendant District Court, D. External link to document
2012-07-18 234 with infringement of U.S. Patent Nos. 6,211,229 (the '"229 patent") and 7,915,307 (the…the '"307 patent") in connection with Mylan's submission to the U.S. Food and Drug…have existed until the expiration ofthe Licensed Patents and any applicable period of exclusivity. …defenses with respect to the '229 and '307 patents are hereby dismissed without prejudice; …Products during the life of the '229 and '307 patents, including any extensions and pediatric exclusivities External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Boehringer Ingelheim
Merck
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.